Initial chemotherapy alone is as effective as initial radiation therapy for patients who have undergone surgery for removal of very malignant brain tumor, reveals a new study.
With this treatment, the patients survive on average more than 30 months without a recurrence, said researchers from Heidelberg and Zurich.
New Approach for Highly Selective Chemotherapy Delivery
A new approach developed by researchers at University of California, Irvine, can vastly improve the targeting of chemotherapeutic drugs to specific cells and organs.
Advertisement
As the tumors can branch out widely into the surrounding tissue, they cannot be completely removed.
The subsequent therapy in the form of combined radiochemotherapy (radiation and chemotherapy) is the current standard treatment, but it is associated with a risk of long-term toxicity to healthy brain tissue, causing the patient to lose cognitive abilities.
![Researchers Show Inhibiting Action Of Enzyme That Makes Cancer Cells Sensitive To Chemotherapy]( "Researchers Show Inhibiting Action Of Enzyme That Makes Cancer Cells Sensitive To Chemotherapy")
Researchers have for the first time shown that inhibiting the action of an enzyme called TAK-1 could make pancreatic cancer cells sensitive to chemotherapy.
Moreover recent studies have shown that combined radiochemotherapy according to current standard practice does not yield better therapy results than radiotherapy alone.
The new NOA (Neurooncology Working Group) study has shown that chemotherapy alone after surgical removal of the tumor has an equivalent result.
"This additional treatment option facilitates the further development of the treatment plan in new combinations with the long-term goal of improving the survival rate," said Professor Wolfgang Wick, Medical Director of the Department of Neurooncology at Heidelberg University Hospital and Head of the Neurooncology Unit at the DKFZ.
The results were published in the Journal of Clinical Oncology.
Source: ANI
ARU
Researchers Show Inhibiting Action Of Enzyme That Makes Cancer Cells Sensitive To Chemotherapy
Researchers have for the first time shown that inhibiting the action of an enzyme called TAK-1 could make pancreatic cancer cells sensitive to chemotherapy.
Advertisement
Moreover recent studies have shown that combined radiochemotherapy according to current standard practice does not yield better therapy results than radiotherapy alone.
The new NOA (Neurooncology Working Group) study has shown that chemotherapy alone after surgical removal of the tumor has an equivalent result.
"This additional treatment option facilitates the further development of the treatment plan in new combinations with the long-term goal of improving the survival rate," said Professor Wolfgang Wick, Medical Director of the Department of Neurooncology at Heidelberg University Hospital and Head of the Neurooncology Unit at the DKFZ.
The results were published in the Journal of Clinical Oncology.
Source: ANI
ARU
Sorafenib, Chemotherapy Combo Slow Breast Cancer Progression
One of the first of a series of trials to investigate the use of sorafenib - a targeted anti-cancer drug - for the treatment of advanced breast cancer...
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
